Showing results (91-100 of 403) with videos related to
Sort By:
Pageof 41
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 12, 2021
The prevalence of epileptic seizures in multiple sclerosis in a large tertiary hospital in AustraliaSuyi Ooi, Tomas Kalincik, Piero Perucca, et al.Epilepsia|February 16, 2011
The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trialsGaetano Zaccara, Pierfranco Gangemi, Piero Perucca, et al.Annals of Neurology|December 31, 2025
Time to Change the Drug Trial Paradigm for Dravet Syndrome: Designing Trials for the Disease Rather than Squeezing the Disease into the TrialIngrid E Scheffer, Piero Perucca, Philippa J KarolyEpilepsia|January 29, 2011
Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysisSylvain Rheims, Emilio Perucca, Michel Cucherat, et al.Epilepsia|May 28, 2008
Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsyEmilio Perucca, James Cloyd, David Critchley, et al.Epilepsia|January 11, 2021
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in EuropeReem Odi, Valentina Franco, Emilio Perucca, et al.Clinical Pharmacokinetics|August 14, 2020
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral FormulationsValentina Franco, Pavel Gershkovich, Emilio Perucca, et al.Epileptic Disorders : International Epilepsy Journal with Videotape|November 9, 2002
Epilepsy in elderly people: management issuesRay Tallis, Paul Boon, Emilio Perucca, et al.Nature Reviews. Drug Discovery|December 2, 2008
LacosamideEmilio Perucca, Uma Yasothan, Gilbert Clincke, et al.CNS Drugs|June 26, 2009
Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disordersGiulia Curia, Giuseppe Biagini, Emilio Perucca, et al.Pageof 41